Sign in
CompletedNo phase

Evaluation of FPT-20 for the Treatment of Spermatogenesis and Semen Disorders

Key facts

Who runs it
Trieu, Nguyen Thi, M.D.
Where
Vietnam1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
16 people enrolled
Started
29 Oct 2020
Ended
20 May 2026
Type of study
Interventional
Treatments tested
  • FPT-20
Record updated
8 June 2026

Who can take part

Age
25 years to 40 years
Sex
Men only
Healthy volunteers
Can take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • The selected person has evidence of spermatogenesis disorder, no sperm, and weak sperm that do not meet the standards in terms of quantity and quality
  • There are signs of orchitis
  • Accepting patients with other comorbidities such as metabolic diseases, congenital or acquired immunodeficiency, HIV/AIDS, HBV, HCV, and Tuberculosis

Who cannot take part

  • Do not select patients with advanced cancer

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This clinical study aims to evaluate the efficacy and safety of a novel, natural-derived formulation (FPT-20) in supporting spermatogenesis. The investigation focuses on the formulation's potential to reduce inflammatory processes and support tissue regeneration within the testicular lobules, seminiferous tubule epithelium, and surrounding connective tissues. Additionally, the study assesses its ability to restore Leydig and Sertoli cell functions in patients with spermatogenic failure secondary to testicular inflammation.

The group in the trial

  • FPT-20 Intervention GroupTreatment being tested

    A single-arm group consisting of 16 infertile men with spermatogenic failure secondary to testicular inflammation. All participants receive a standardized therapeutic dose of the natural-derived formulation FPT-20 daily for a duration of 6 to 12 months.

    Treatment: FPT-20

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Open-Label Study on the Efficacy of a New Natural Origin Product (FPT-20) in Improving Spermatogenesis and Semen Parameters in Men With Spermatogenic Failure.
Record updated
8 June 2026